Massachusetts Psychiatric Services offers a nasal spray esketamine treatment for patients who have a diagnosis of:

  • Suicidal Ideation
  • Treatment-Resistant Depression

This is an FDA approved treatment for treatment resistant depression. A third of the patients do not respond to oral antidepressants. Esketamine can improve the mood much quicker than the traditional oral antidepressants.

It could work where some of the antidepressants have failed to do so. The treatments are provided in our office under the psychiatrists’ supervision.

For screening and scheduling for esketamine please call 508.418.6888 x 108 or send an email to

Below is a PHQ-9 Depression Questionnaire, to be completed. If you think you are scoring for a significant depression, contact us at the extension below.

Certified Outpatient SPRAVATO® Treatment Center

Contact for scheduling Esketamine screening at

508.418.6888 x 108

or fill the form below